← Mirum Pharmaceuticals, Inc. MIRM
Market Price
$100.64
Market Cap
$6.02B
P/E Ratio
N/A
Revenue (FY 2025)
↑54.7% YoY
$521.31M
3-Yr CAGR: 89.1%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↑488.0% YoY
$54.87M
FCF Yield: 0.91%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MIRM)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | — | — | — | — | — | — | — | — | — | — |
| FY 2019 | $2.2M | — | $1.8M | — | — | — | — | $-39.4M | $-39.6M | — |
| FY 2020 | — | -100.0% | — | — | — | — | — | $-89.1M | $-89.3M | -125.3% |
| FY 2021 | $19.1M | — | $1.5M | — | — | — | — | $-132.8M | $-132.8M | -48.7% |
| FY 2022 | $77.1M | +302.7% | $61.1M | — | — | — | — | $-120.1M | $-120.4M | +9.3% |
| FY 2023 | $186.4M | +141.8% | $139.3M | — | — | — | — | $-70.9M | $-71.1M | +41.0% |
| FY 2024 | $336.9M | +80.8% | $255.2M | — | — | — | — | $10.3M | $9.3M | +113.1% |
| FY 2025 | $521.3M | +54.7% | $421.1M | — | — | — | — | $55.8M | $54.9M | +488.0% |
Valuation
Market Price
$100.64
Market Cap
$6.02B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
19.50
FCF Yield
0.91%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
80.77%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.62x
Revenue 3-Yr CAGR
89.13%
Financial Health & Liquidity
Current Ratio
0.09
Cash Ratio
1.51
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$296.68M
Total Debt
N/A
Book Value / Share
$5.16
Cash Flow Efficiency
Operating Cash Flow
$55.83M
Capital Expenditures (CapEx)
$954.00K
Free Cash Flow
$54.87M
OCF / Revenue
10.71%
FCF / Revenue
10.53%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$5.16
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$842.81M
Total Liabilities
$842.81M
Stockholders' Equity
$314.69M
Current Assets
$18.14M
Current Liabilities
$196.19M